BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11310208)

  • 1. Quantitative analysis of telomerase activity and telomerase reverse transcriptase expression in renal cell carcinoma.
    Hara T; Noma T; Yamashiro Y; Naito K; Nakazawa A
    Urol Res; 2001 Feb; 29(1):1-6. PubMed ID: 11310208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
    Fan Y; Liu Z; Fang X; Ge Z; Ge N; Jia Y; Sun P; Lou F; Björkholm M; Gruber A; Ekman P; Xu D
    Clin Cancer Res; 2005 Jun; 11(12):4331-7. PubMed ID: 15958614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hTERT is a critical determinant of telomerase activity in renal-cell carcinoma.
    Kanaya T; Kyo S; Takakura M; Ito H; Namiki M; Inoue M
    Int J Cancer; 1998 Nov; 78(5):539-43. PubMed ID: 9808519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of telomerase status by semiquantitative and in situ assays, and by real-time reverse transcription-polymerase chain reaction (telomerase reverse transcriptase) assay in bladder carcinomas.
    Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
    BJU Int; 2003 Apr; 91(6):567-72. PubMed ID: 12656916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
    Ohuchida K; Mizumoto K; Ogura Y; Ishikawa N; Nagai E; Yamaguchi K; Tanaka M
    Clin Cancer Res; 2005 Mar; 11(6):2285-92. PubMed ID: 15788678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hTERT expression in sporadic renal cell carcinomas.
    Paradis V; Bièche I; Dargère D; Bonvoust F; Ferlicot S; Olivi M; Lagha NB; Blanchet P; Benoît G; Vidaud M; Bedossa P
    J Pathol; 2001 Sep; 195(2):209-17. PubMed ID: 11592100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the human telomerase reverse transcriptase is not related to telomerase activity in normal and malignant renal tissue.
    Rohde V; Sattler HP; Bund T; Bonkhoff H; Fixemer T; Bachmann C; Lensch R; Unteregger G; Stoeckle M; Wullich B
    Clin Cancer Res; 2000 Dec; 6(12):4803-9. PubMed ID: 11156238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
    Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ
    Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity.
    Zaffaroni N; Della Porta C; Villa R; Botti C; Buglioni S; Mottolese M; Grazia Daidone M
    J Pathol; 2002 Sep; 198(1):37-46. PubMed ID: 12210061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization.
    Kammori M; Kanauchi H; Nakamura K; Kawahara M; Weber TK; Mafune K; Kaminishi M; Takubo K
    Int J Oncol; 2002 Jan; 20(1):15-21. PubMed ID: 11743637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas].
    Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
    Prog Urol; 2003 Apr; 13(2):238-45. PubMed ID: 12765058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase, hTERT and splice variants in Barrett's oesophagus and oesophageal adenocarcinoma.
    Barclay JY; Morris A; Nwokolo CU
    Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):221-7. PubMed ID: 15674101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer.
    Hara H; Yamashita K; Shinada J; Yoshimura H; Kameya T
    Lung Cancer; 2001 Nov; 34(2):219-26. PubMed ID: 11679180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase activity and expression of human telomerase catalytic subunit gene in esophageal tissues.
    Tominaga T; Kashimura H; Suzuki K; Nakahara A; Tanaka N; Noguchi M; Itabashi M; Ohkawa J
    J Gastroenterol; 2002; 37(6):418-27. PubMed ID: 12108675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
    Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
    Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of telomerase genes in thyroid carcinoma.
    Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
    Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma.
    Toshikuni N; Nouso K; Higashi T; Nakatsukasa H; Onishi T; Kaneyoshi T; Kobayashi Y; Kariyama K; Yamamoto K; Tsuji T
    Br J Cancer; 2000 Feb; 82(4):833-7. PubMed ID: 10732755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The opposing effect of hypoxia-inducible factor-2alpha on expression of telomerase reverse transcriptase.
    Lou F; Chen X; Jalink M; Zhu Q; Ge N; Zhao S; Fang X; Fan Y; Björkholm M; Liu Z; Xu D
    Mol Cancer Res; 2007 Aug; 5(8):793-800. PubMed ID: 17699105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of telomerase activity for differential analysis of multifocal renal cell carcinomas.
    Fiedler W; Junker K; Schlichter A; Schubert J; Ernst G; Dahse R; Claussen U
    Kidney Int; 1999 Oct; 56(4):1286-8. PubMed ID: 10504476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma.
    Takuma Y; Nouso K; Kobayashi Y; Nakamura S; Tanaka H; Matsumoto E; Fujikawa T; Suzuki M; Hanafusa T; Shiratori Y
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1300-4. PubMed ID: 15482538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.